Sr. VP Mktg & Clinical Affairs Burns Kristie was granted 24,069 shares and sold $70,753 worth of shares (4,830 units at $14.65), increasing direct ownership by 30% to 84,008 units (SEC Form 4)
$TCMD
Medical/Dental Instruments
Health Care
| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
| Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. | |||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
TACTILE SYSTEMS TECHNOLOGY INC [ TCMD ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
|
3. Date of Earliest Transaction
(Month/Day/Year) 02/20/2025 | ||||||||||||||||||||||||||
|
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Common Stock | 02/20/2025 | A | 3,359(1) | A | $0 | 68,128(2) | D | |||
| Common Stock | 02/20/2025 | A | 4,131(3) | A | $0 | 72,259 | D | |||
| Common Stock | 02/20/2025 | A | 16,579(4) | A | $0 | 88,838 | D | |||
| Common Stock | 02/24/2025 | S | 4,830(5) | D | $14.6486(6) | 84,008 | D | |||
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Explanation of Responses: |
| 1. On February 22, 2023, the reporting person was granted performance stock units ("PSUs"), with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2024. As determined on February 20, 2025, based on actual performance for 2024, the reporting person earned 3,359 PSUs. Those earned PSUs vested on February 20, 2025. |
| 2. Includes 2,195 shares acquired on May 15, 2024 pursuant to the issuer's employee stock purchase plan. |
| 3. On February 21, 2024, the reporting person was granted PSUs, with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2024. As determined on February 20, 2025, based on actual performance for 2024, the reporting person earned 4,131 PSUs. Those PSUs are scheduled to vest on the date in 2026 that the Compensation and Organization Committee determines the number of PSUs earned with respect to the 2025 performance year. |
| 4. Represents restricted stock units ("RSUs") that vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. |
| 5. Consists of shares sold to cover taxes associated with the settlement of stock units. |
| 6. Reflects the weighted average price of 4,830 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 24, 2025 with sale prices ranging from $14.4301 to $14.82 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| /s/ Jonathan Zimmerman, Attorney-in-Fact | 02/24/2025 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||